London, UK, 20 October 2025: giles AI, a company making advanced research tools accessible to all and simplifying how ...
In a recent case study, the ModernVivo platform reduced the development time of a pancreatic cancer study by 75%, transforming months of preparation into days. Recognizing the diverse realities of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback